Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Value Peer-spectives
Filter by Topic
ASCO’s Value Framework
Commentary
Employers’ Perspective
Letter to our Readers
Oncologist–Patient Communication
Patient Communication
Patient Perspective
Payer’s Perspective
Practice Management
Testimonials
The Patient Perspective
Value in Oncology
Value Propositions
VBCC Perspectives
New Payer-Oncologist Collaboration to Curb Cancer Care Costs, Improve Quality, Launched in Michigan
Value Propositions
,
Value Peer-spectives
October 2012, Vol 3, No 7
In September, Cardinal Health Specialty Solutions announced the launch of a new collaboration initiative with Health Alliance Plan (HAP) and Physician Resource Management to establish an evidence-based clinical pathways program aimed at reducing the costs of cancer care while improving quality of care.
Read Article
The IOM Considers the Economics of Genome-Based Targeted Drug Development
Value Propositions
,
Value Peer-spectives
October 2012, Vol 3, No 7
The Institute of Medicine (IOM) recently held a roundtable discussion on the status of genome-based drug development.
Read Article
Ovarian Cancer Therapy Moving Toward Personalized Medicine
Value Propositions
,
Value Peer-spectives
October 2012, Vol 3, No 7
The recent discovery of 3 subtypes of high-grade serous ovarian cancer (HGSOC) by researchers at Dana-Farber Cancer Institute will soon enable oncologists to determine which of their patients with HGSOC—the most common type of ovarian cancer—are most likely to benefit from a certain class of drugs.
Read Article
NCCN Awards 5 Grants to Study Afatinib Efficacy in Several Solid Tumors
Value Propositions
,
Value Peer-spectives
September 2012, Vol 3, No 6
Read Article
Physical Activity Can Lower Risk of Invasive Breast Cancer
Value Propositions
,
Value Peer-spectives
September 2012, Vol 3, No 6
Read Article
A New Molecular Cervical Cancer Test Will Aid Accurate Diagnosis
Value Propositions
,
Value Peer-spectives
September 2012, Vol 3, No 6
Quest Diagnostics, the leading provider of diagnostic testing, has introduced a new laboratory test that identifies molecular changes to cervical cells that may signal increased risk for cervical cancer.
Read Article
The Number of Cancer Survivors on the Rise in the United States
Value Propositions
,
Value Peer-spectives
September 2012, Vol 3, No 6
Read Article
Researchers Highlight Benefits of Exercise for Patients with Cancer
Value Propositions
,
Value Peer-spectives
July 2012, Vol 3, No 5
Several researchers at the University of Rochester Medical Center have been studying the effects of exercise on patients with cancer for some time now.
Read Article
First US Hospital Integrates Psychosocial Support Services in Its Cancer Center
Value Propositions
,
Value Peer-spectives
July 2012, Vol 3, No 5
Greenville Hospital System (GHS) has launched the Center for Integrative Oncology and Survivorship, which offers emotional services for cancer survivors developed by Cancer Support Community (CSC), an international provider of cancer-related social and emotional services.
Read Article
World’s First Pediatric Lymphoma Research Center Launched
Value Propositions
,
Value Peer-spectives
July 2012, Vol 3, No 5
Texas Children’s Cancer Center has opened the first center dedicated entirely to the research, care, and treatment of children with lymphoma. The Fayez Sarofim Lymphoma Center at Texas Children’s Cancer Center was made possible by a gift of $10 million to Texas Children’s Hospital.
Read Article
Page 10 of 16
5
6
7
8
9
10
11
12
13
14
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
Wayne Kuznar
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma